The ethics of clinical research in the era of COVID-19
There is an urgent need for increased understanding of COVID-19 and strategies for its prevention, treatment, and mitigation. All participants in the research enterprise, including institutional review boards, have an ethical duty to protect participants and ensure that the benefits gained from such...
Main Authors: | Juliana N. Vitti, Robert Vitti, Karen Chu, Scott Mellis |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-03-01
|
Series: | Frontiers in Public Health |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2024.1359654/full |
Similar Items
-
Rapid Establishment of a Biospecimen Resource To Study the Global Impact of COVID-19 Vaccines
by: K. E. Berliner, et al.
Published: (2023-08-01) -
Ethical Considerations for Unblinding and Vaccinating COVID-19 Vaccine Trial Placebo Group Participants
by: Jenna Rose Stoehr, et al.
Published: (2021-06-01) -
The ethics of COVID-19 clinical trials: New considerations in a controversial area
by: Zhenzhen Han, et al.
Published: (2020-09-01) -
Vaccine trials during a pandemic: potential approaches to ethical dilemmas
by: Manaf Alqahtani, et al.
Published: (2021-09-01) -
Clinical trials during the COVID-19 pandemic: Challenges of putting scientific and ethical principles into practice
by: Arun Bhatt
Published: (2020-01-01)